fructose-1,6-diphosphate and mocetinostat

fructose-1,6-diphosphate has been researched along with mocetinostat in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akimitsu, T; Carden, DL; Gute, DC; Korthuis, RJ; White, JA1
Blennerhassett, P; Langer, JC; Sohal, SS1
Gong, FL; Gong, Q; Hu, LY; Jin, XB; Yang, H; Yin, H; Zhu, JY1

Other Studies

3 other study(ies) available for fructose-1,6-diphosphate and mocetinostat

ArticleYear
Fructose-1,6-diphosphate or adenosine attenuate leukocyte adherence in postischemic skeletal muscle.
    The American journal of physiology, 1995, Volume: 269, Issue:5 Pt 2

    Topics: Adenosine; Animals; Capillary Permeability; Cell Adhesion; Dogs; Female; Fructosediphosphates; Immunologic Factors; Ischemia; Leukocytes; Male; Mice; Mice, Inbred Strains; Muscles; Neutrophils; Peroxidase; Reperfusion; Superoxides

1995
Mucosal permeability after subclinical intestinal ischemia-reperfusion injury: an exploration of possible mechanisms.
    Journal of pediatric surgery, 1995, Volume: 30, Issue:4

    Topics: Animals; Chromium Radioisotopes; Dinoprostone; Edetic Acid; Eicosanoids; Enterocolitis, Pseudomembranous; Free Radicals; Fructosediphosphates; Immunologic Factors; Intestinal Absorption; Intestinal Mucosa; Intestines; Male; Neutrophils; Peroxidase; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Weaning

1995
Fructose-1,6-diphosphate attenuates acute lung injury induced by lipopolysaccharide in mice.
    International immunopharmacology, 2008, Dec-20, Volume: 8, Issue:13-14

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Disease Models, Animal; Fructosediphosphates; Interleukin-6; Lipopolysaccharides; Lung; Macrophages, Alveolar; Male; Mice; Mice, Inbred BALB C; NF-kappaB-Inducing Kinase; Nitric Oxide Synthase Type II; Peroxidase; Protein Serine-Threonine Kinases; Signal Transduction; Tumor Necrosis Factor-alpha

2008